share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Recursion Pharmaceuticals | 4：持股变动声明
SEC announcement ·  04/03 17:44
Moomoo AI 已提取核心信息
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on April 1, 2024. The transaction involved a grant of 1,467 shares of Class A Common Stock at no cost. Following the transaction, Burrell's direct holdings in the company increased to a total of 56,314 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on April 1, 2024. The transaction involved a grant of 1,467 shares of Class A Common Stock at no cost. Following the transaction, Burrell's direct holdings in the company increased to a total of 56,314 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
与 Recursion Pharmicals, Inc. [RXRX] 关联的 Terry-Ann Burrell 于 2024 年 4 月 1 日完成了股票收购。该交易涉及免费授予1,467股A类普通股。交易完成后，伯勒尔在该公司的直接持股量增加到总共56,314股。该补助金是公司股票薪酬计划的一部分，反映了保持员工利益与股东利益一致的持续承诺。
与 Recursion Pharmicals, Inc. [RXRX] 关联的 Terry-Ann Burrell 于 2024 年 4 月 1 日完成了股票收购。该交易涉及免费授予1,467股A类普通股。交易完成后，伯勒尔在该公司的直接持股量增加到总共56,314股。该补助金是公司股票薪酬计划的一部分，反映了保持员工利益与股东利益一致的持续承诺。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息